-
A decision by a federal agency to halt a landmark infection prevention effort continues to create fallout, with the American Hospital Association (AHA) issuing a strongly worded letter protesting the move.
-
The Centers for Disease Control and Prevention is drafting comprehensive new guidelines for urinary tract infections (UTIs), a complication so common and typically treatable that it has been accepted with a sort of benign neglect by the health care system.
-
The Centers for Disease Control and Prevention in conjunction with Kaiser Permanente's Northern California Division of Research will formally investigate an unexplained but persistently reported skin condition known as Morgellons.
-
A recent controversial move by a federal health agency to shut down a highly successful infection prevention program because it appeared to be involved in human research rather than quality improvement has ominous implications for traditional infection control activities, a leading epidemiologist tells Hospital Infection Control.
-
The Michigan Health & Hospital Association's Keystone Center for Patient Safety & Quality has created a "bladder bundle" of measures to prevent urinary tract infections. Some of the key recommendations for implementation of the bundle are summarized as follows:
-
Merck & Co. has initiated a voluntary recall in the United States for 10 lots of PedvaxHIB® [Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)] and two lots of COMVAX® [Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine].
-
Recall of a dozen lots of two Haemophilus influenzae type b (Hib) vaccines and suspension of production by a major manufacturer will result in a national shortage that could put children at risk and will certainly trouble physicians and parents in the short run, Julie Gerberding, MD, MPH, director of the Centers for Disease Control and Prevention, warns.
-
Though they are the most common infectious complication in hospitals, urinary tract infections (UTIs) get no respect.
-
Alarmed by continuing deaths and severe adverse reactions after treatment for latent tuberculosis, the Centers for Disease Control and Prevention is seeking funding approval for a national surveillance system to track the events.
-
The Centers for Disease Control and Prevention is responding to a recent Washington Post report that CDC estimates of new HIV infections in Americans annually may be 50% higher than previously believed.
